From Benznidazole to new drugs: Nanotechnology contribution in Chagas disease

DC Gomes, TS Medeiros, EL Alves Pereira… - International Journal of …, 2023 - mdpi.com
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …

Trypanosoma cruzi calreticulin: immune evasion, infectivity, and tumorigenesis

G Ramírez-Toloza, E Sosoniuk-Roche, C Valck… - Trends in …, 2020 - cell.com
To successfully infect, Trypanosoma cruzi evades and modulates the host immune
response. T. cruzi calreticulin (TcCalr) is a multifunctional, endoplasmic reticulum (ER) …

The cost of being a killer's accomplice: Trypanosoma cruzi impairs the fitness of kissing bugs

G Cordero-Montoya, AL Flores-Villegas… - Parasitology …, 2019 - Springer
Relatively little is known about the fitness effects and life history trade-offs in medically
important parasites and their insect vectors. One such case is the triatomine bugs and the …

Clinical and epidemiological characterization of acute Chagas disease in Casanare, Eastern Colombia, 2012–2020

CY Rincón-Acevedo, AS Parada-García… - Frontiers in …, 2021 - frontiersin.org
Background: Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is
considered a public health problem in Latin America. In Colombia, it affects more than …

Computational drug repositioning for chagas disease using protein-ligand interaction profiling

A Juárez-Saldivar, M Schroeder, S Salentin… - International journal of …, 2020 - mdpi.com
Chagas disease, caused by Trypanosoma cruzi (T. cruzi), affects nearly eight million people
worldwide. There are currently only limited treatment options, which cause several side …

A phased genome assembly of a Colombian Trypanosoma cruzi TcI strain and the evolution of gene families

MC Hoyos Sanchez, HS Ospina Zapata, BD Suarez… - Scientific Reports, 2024 - nature.com
Chagas is an endemic disease in tropical regions of Latin America, caused by the parasite
Trypanosoma cruzi. High intraspecies variability and genome complexity have been …

Phylogenetic diversity of two common Trypanosoma cruzi lineages in the Southwestern United States

CA Flores-López, EA Mitchell, CE Reisenman… - Infection, Genetics and …, 2022 - Elsevier
Trypanosoma cruzi is the causative agent of Chagas disease, a devastating parasitic
disease endemic to Central and South America, Mexico, and the USA. We characterized the …

Review of American trypanosomiasis in southern Mexico highlights opportunity for surveillance research to advance control through the one health approach

DD Velázquez-Ramírez, AA Pérez de Léon… - Frontiers in Public …, 2022 - frontiersin.org
American trypanosomiasis (AT), also known as Chagas disease, is a vector-borne zoonosis
of global public health importance caused by the protozoan parasite Trypanosoma cruzi (T …

New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes

MMA Silvestrini, GD Alessio, BED Frias… - Frontiers in …, 2024 - frontiersin.org
Chagas disease, caused by Trypanosoma cruzi, remains a serious public health problem
worldwide. The parasite was subdivided into six distinct genetic groups, called “discrete …

Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi

JW de Freitas Oliveira, TM Torres, CJG Moreno… - Scientific Reports, 2021 - nature.com
Chagas disease is caused by Trypanosoma cruzi and affects thousands of people. Drugs
currently used in therapy are toxic and have therapeutic limitations. In addition, the genetic …